Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era

A breakthrough infection occurring with 13-valent pneumococcal conjugate vaccine (PCV13) in Turkey are previously described. A breakthrough infection is defined as IPD in a child who had received ≥ 1 PCV-7 or PCV-13 and for which the pneumococcal isolate was a vaccine serotype. During one year perio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Tanır Basaranoglu, Sevgen, Karadag Oncel, Eda, Aykac, Kubra, Ozsurekci, Yasemin, Cengiz, Ali Bülent, Kara, Ates, Ceyhan, Mehmet
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2016
Aiheet:
Short Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404356/
https://ncbi.nlm.nih.gov/pubmed/27905836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1256519
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia